Efficacy of Multi-waved Locked System Laser Versus Cold Compression Therapy on Breast Cancer-related Lymphoedema
Lymphedema
About this trial
This is an interventional treatment trial for Lymphedema
Eligibility Criteria
Inclusion Criteria: Female patients with unilateral BCRL. Age of patients above 18 years old Patient history of modified radical mastectomy, chemotherapy and/or radiotherapy. Patients undertaken have history or current hormonal treatment. Patients with moderate lymphoedema (20-40% increase in extremity volume) Exclusion Criteria: Patients who have severe co-morbid diseases. Presence of other cancers, cancer recurrence, lymphatic malformation, or vascular disease Patients who are having current chemotherapy and/or radiotherapy. Patients who have bilateral lymphedema, current metastases, elephantiasis, infection, lymphangiosis carcinomatosa, cellulitis, venous thrombosis, or congestive heart failure Patients with musculoskeletal disorders affecting upper extremity.
Sites / Locations
- Kasr El-Einy Center of Radiation Oncology and Nuclear Medicine, Faculty of Medicine, Cairo University
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Active Comparator
Study group (A) Multi-waved Locked System Laser group
Study group (B) Cold Compression Therapy group
Group (C) Control group